Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2019–2024 · research · R01
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications
Jingfei Ma · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
Jonathan M Kurie · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Strategies for Persistent Agitated Delirium in Palliative Care
David Hui · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Formation en recherche post-diplôme professionnel (fellowship)
Formation en recherche post-diplôme professionnel (fellowship) — Cancer de la tête et du cou, Génomique
Anastasios Maniakas · The University of Texas MD Anderson Cancer Center · funded by Fonds de Recherche du Québec - Santé
2019 · grant · Academic Research
Neoadjuvant Treatment Response Monitoring of Breast Cancer With Molecular Photoacoustic Imaging
Richard Bouchard · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019 · career development · Young Investigator Award
Investigation of combination therapy with pemetrexed, A2BR inhibitor, and anti-PD-L1 in MTAP deficient bladder cancer
Omar Alhalabi · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019–2024 · research · R01
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients
Guojun Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
Assessments of Tumor Perfusion With Dynamic Contrast–Enhanced Multispectral Optoacoustic Tomography
Mark D Pagel · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · research · R01
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
Jianjun Zhang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · grant · Academic Research
The EZH2 Deubiquitinase ZRANB1 as a Therapeutic Target in Breast Cancer
Li Ma · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019 · grant · Academic Research
Role of S1PR1 in Exercise-Induced Tumor Vascular Remodeling
Keri Schadler · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2019–2024 · research · R01
Adoptive T Cell Therapy for Pancreatic Cancer
Cassian Yee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Rigorous and reproducible mutational analysis of the urinary exosomal DNA
Colin P.N. Dinney · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · cooperative agreement · UG1
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
Powel H Brown · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Integrative approaches for decoding the function and regulation of unconventional RNA translation
Yiwen Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Role of SETD5 in Chromatin Regulation and Tumorigenesis
Pawel K. Mazur · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device
John Paul Christodouleas · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · cooperative agreement · U01
Building a Diverse Biomedical Workforce Through Communication Across Difference
Carrie A. Cameron · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device
John Paul Christodouleas · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients
Guojun Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients
Guojun Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2023 · research · R01
Dynamic Prediction of Renal Failure Using Longitudinal Prognostic Information among Patients with Chronic Kidney Disease and Kidney Transplant
Brad C Astor · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Combating Breast Cancer Brain Metastasis by Blocking the Two-Pronged Driver Kinase Function of CDK5
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
Laura Beretta · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019 · career development · Young Investigator Award
Use of Radiomic Characteristics associated with Decreased T-Cell Response to predict In-Field Failure after Definitive Chemoradiation for Anal Squamous Cell Carcinoma
Lauren Colbert · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019 · career development · Young Investigator Award
Treatment of Multiple Myeloma with CAR-NK Cells and TIGIT blockade
Paul Lin · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019 · training · ASH HONORS Award: Residents
ASH HONORS Award 2019: Nikeshan Jeyakumar
Nikeshan Jeyakumar · The University of Texas MD Anderson Cancer Center · funded by American Society of Hematology
2019 · career development · Career Development Award
Cell-free DNA (cfDNA) to detect minimal residual disease, predict therapeutic response, and characterize immunogenomic evolution in early-stage NSCLC treated with neoadjuvant immunotherapy
Vincent Lam · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019 · career development · Young Investigator Award
Uncoupling Tumor Immunity from Autoimmunity: The role of Interleukin-6 and Th17 cells in checkpoint inhibitor mediated enterocolitis
Daniel Johnson · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019 · career development · Career Development Award
Optimizing targeted therapy for HER2 mutant non-small cell lung cancer (NSCLC) and other solid tumors
Yasir Elamin · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019 · career development · Young Investigator Award
Characterizing and targeting immune exclusion in TGF-ß-activated CMS4 colorectal cancer
Amir Mehrvarz Sarshekeh · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019 · career development · Young Investigator Award
Prevention of Therapy-Related Myeloid Neoplasms Associated with Clonal Hematopoiesis of Indeterminate Potential
Kelly Chien · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019 · fellowship · Borsa di ricerca
Geni responsabili per la farmaco-resistenza nel tumore ovarico
Francesca Citron · The University of Texas MD Anderson Cancer Center · funded by Fondazione Umberto Veronesi
2019 · career development · Career Development Award
Targeting synthetic vulnerabilities induced by stress responses in SMARCB1-deficient malignancies
Pavlos Msaouel · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2019–2023 · research · SU2C MEG VOSBURG T-CELL LYMPHOMA DREAM TEAM
Tailoring CAR-based Immunotherapy Strategies to T-Cell Lymphoma
Helen E. Heslop · The University of Texas MD Anderson Cancer Center · funded by Stand Up To Cancer
2019 · fellowship · AACR-Pfizer Immuno-oncology Research Fellowship
Overcoming anti-PD-1/PD-L1 resistance in triple-negative breast cancer
Zhou Jiang · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2019–2025 · program · P50
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study
Laura Beretta · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Career Enhancement Program
Scott Kopetz · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2024 · program · P50
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
Michael Davies · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2019–2025 · program · P50
Core 3-Biostatistics
J. Jack Lee · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
